Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Sees Large Decrease in Short Interest

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) saw a significant decrease in short interest in the month of March. As of March 13th, there was short interest totaling 473 shares, a decrease of 81.2% from the February 26th total of 2,513 shares. Based on an average daily volume of 1,606 shares, the short-interest ratio is currently 0.3 days. Based on an average daily volume of 1,606 shares, the short-interest ratio is currently 0.3 days.

Hikma Pharmaceuticals Price Performance

HKMPY traded up $0.07 during trading on Tuesday, reaching $33.05. The stock had a trading volume of 782 shares, compared to its average volume of 1,961. The stock’s 50 day moving average is $39.67 and its two-hundred day moving average is $42.61. Hikma Pharmaceuticals has a one year low of $31.80 and a one year high of $56.94.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.

The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.